BCL2A1 and major depressive disorder: Recently, accumulating studies have indicated glucocorticoid receptors (GRs), one type of glucocorticoids cognate receptors, through which endogenous glucocorticoids serve as potent negative regulators of HPA axis activity, is one of the most important, striking and innovative targets in the pathophysiology and therapy of depression [18–20].